Nicholas M. Katritsis

This paper develops a multimodal therapy for CML combining computational target analysis with nanoparticle-based drug delivery and validates its efficacy in mouse models.

The paper presents an automated pipeline using NLP and chemical/disease embeddings to classify DILI-related literature, achieving high F1-scores in distinguishing DILI-positive from negative papers.

This paper introduces DILIc, an AI classifier that identifies Drug-Induced Liver Injury literature using NLP and ML, achieving high accuracy in cross-validation and external validation.